A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.
Piyu Parth NaikPublished in: Scars, burns & healing (2022)
Toxic epidermal necrolysis (TEN) is a serious skin reaction with a 30% chance of mortality. Commonly TEN is caused by medicines and results in a burn like appearance and sensation in patients. Usually administered medicine is cleared effectively by the human body but when the clearance of few metabolites from medicine is disrupted due to few genes, it leads to an ominous response by the body. This response involves several intermediate chemicals that primarily attack skin cells. Treatment guidelines differ globally. Supportive care is highly accepted, along with early discontinuation of all medicine. Currently, a multi-faceted treatment regimen is favored. Treatments like corticosteroids to immunoglobulins are under constant evaluation. Identification of the perfect combination of treatment needs confirmation from robust randomized controlled trials.
Keyphrases
- healthcare
- wound healing
- endothelial cells
- end stage renal disease
- palliative care
- newly diagnosed
- systematic review
- clinical trial
- chronic kidney disease
- combination therapy
- dna methylation
- type diabetes
- cardiovascular events
- oxidative stress
- risk factors
- replacement therapy
- cell cycle arrest
- pain management
- prognostic factors
- coronary artery disease
- chronic pain
- study protocol
- functional connectivity
- meta analyses